To main content

Impact of Variables Through the Value Chain on the End Product Quality of Sea Food

Abstract

Salmon (Salmo salar) is an important species in Norwegian aquaculture and the Brown crab (Cancer pagurus) is a commercially important shellfish species. The industry export the main part of the salmon gutted or as fillets, and sell the crab as whole crab, fresh or cooked. Roe from various species in the cod family is commonly used in spreads, dinners and tarama.   These raw materials are rich in omega 3 fatty acids and phospholipids, and more product development should be done to increase the human consumption.  A good sensory and nutritional quality is of importance for the consumer acceptance of the end product. In order to prevent oxidation and loss of nutrients, there is a need for more knowledge about critical variables in the value chain.   A  value chain starting with production of salmon feed and ending with a stored end product was carried out using a combined split plot, fractional and mixture design. Salmon was feeded with different levels of omega 3 fatty acids and vitamin E. Fractions from each group were processed and stored under various conditions and secondary processed into model end products including various mixtures of salmon, crab and/or cod roe (Gadus macrocephalus).   The raw materials were analysed for amino- and fatty acid composition and contents of ash, water, lipid, total protein and vitamin E. Parameters of protein and fat oxidation were followed through the value chain. Odour, headspace oxygen and carbon dioxide/carbonyl, pH and microbial growth were also measured during the storage of end products. The stability of the products were influenced by several variables through the entire value chain.   The support from the Research Council of Norway is gratefully acknowledged. 

Category

Academic lecture

Language

English

Author(s)

Affiliation

  • SINTEF Community / Infrastructure
  • SINTEF Ocean / Fisheries and New Biomarine Industry
  • SINTEF Industry / Biotechnology and Nanomedicine

Presented at

WEFTA 2008 38th WEFTA Annual Meeting

Place

Florence, Italy

Date

17.09.2008 - 19.09.2008

Year

2008

View this publication at Cristin